190 related articles for article (PubMed ID: 35328450)
1. Reduced Percentage of CD14
Kowalska W; Zarobkiewicz M; Tomczak W; Woś J; Morawska I; Bojarska-Junak A
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328450
[TBL] [Abstract][Full Text] [Related]
2. Pro- vs. Anti-Inflammatory Features of Monocyte Subsets in Glioma Patients.
Lehman N; Kowalska W; Zarobkiewicz M; Mazurek M; Mrozowska K; Bojarska-Junak A; Rola R
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768201
[TBL] [Abstract][Full Text] [Related]
3. Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
Lapuc I; Bolkun L; Eljaszewicz A; Rusak M; Luksza E; Singh P; Miklasz P; Piszcz J; Ptaszynska-Kopczynska K; Jasiewicz M; Kaminski K; Dabrowska M; Bodzenta-Lukaszyk A; Kloczko J; Moniuszko M
Oncol Rep; 2015 Sep; 34(3):1269-78. PubMed ID: 26135617
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD163 and HLA-DR molecules on the monocytes in chronic lymphocytic leukemia patients.
Kowalska W
Folia Histochem Cytobiol; 2020; 58(1):17-24. PubMed ID: 32176313
[TBL] [Abstract][Full Text] [Related]
5. Maximal Exercise Alters the Inflammatory Phenotype and Response of Mononuclear Cells.
Slusher AL; Zúñiga TM; Acevedo EO
Med Sci Sports Exerc; 2018 Apr; 50(4):675-683. PubMed ID: 29112629
[TBL] [Abstract][Full Text] [Related]
6. Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis.
Xiang Y; Liang B; Zhang X; Zheng F
Int J Med Sci; 2020; 17(14):2171-2179. PubMed ID: 32922178
[No Abstract] [Full Text] [Related]
7. CD16(+) monocyte subsets are increased in large abdominal aortic aneurysms and are differentially related with circulating and cell-associated biochemical and inflammatory biomarkers.
Ghigliotti G; Barisione C; Garibaldi S; Brunelli C; Palmieri D; Spinella G; Pane B; Spallarossa P; Altieri P; Fabbi P; Sambuceti G; Palombo D
Dis Markers; 2013; 34(2):131-42. PubMed ID: 23348634
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD206 and CD163 on intermediate CD14
Li X; Du N; Xu G; Zhang P; Dang R; Jiang Y; Zhang K
Virus Res; 2018 Jul; 253():92-102. PubMed ID: 29857122
[TBL] [Abstract][Full Text] [Related]
9. The "Intermediate" CD14
Wildgruber M; Aschenbrenner T; Wendorff H; Czubba M; Glinzer A; Haller B; Schiemann M; Zimmermann A; Berger H; Eckstein HH; Meier R; Wohlgemuth WA; Libby P; Zernecke A
Sci Rep; 2016 Dec; 6():39483. PubMed ID: 27991581
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the CD14++CD16+ monocyte population in human bone marrow.
Mandl M; Schmitz S; Weber C; Hristov M
PLoS One; 2014; 9(11):e112140. PubMed ID: 25369328
[TBL] [Abstract][Full Text] [Related]
11. The slan antigen identifies the prototypical non-classical CD16
Tamassia N; Bianchetto-Aguilera F; Gasperini S; Grimaldi A; Montaldo C; Calzetti F; Gardiman E; Signoretto I; Castellucci M; Barnaba V; Tripodi M; Cassatella MA
Front Immunol; 2023; 14():1287656. PubMed ID: 37965335
[TBL] [Abstract][Full Text] [Related]
12. TNF-α Inhibitors Decrease Classical CD14
Batko B; Schramm-Luc A; Skiba DS; Mikolajczyk TP; Siedlinski M
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30642076
[TBL] [Abstract][Full Text] [Related]
13. Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics.
Liaskou E; Zimmermann HW; Li KK; Oo YH; Suresh S; Stamataki Z; Qureshi O; Lalor PF; Shaw J; Syn WK; Curbishley SM; Adams DH
Hepatology; 2013 Jan; 57(1):385-98. PubMed ID: 22911542
[TBL] [Abstract][Full Text] [Related]
14. slan-defined subsets of CD16-positive monocytes: impact of granulomatous inflammation and M-CSF receptor mutation.
Hofer TP; Zawada AM; Frankenberger M; Skokann K; Satzl AA; Gesierich W; Schuberth M; Levin J; Danek A; Rotter B; Heine GH; Ziegler-Heitbrock L
Blood; 2015 Dec; 126(24):2601-10. PubMed ID: 26443621
[TBL] [Abstract][Full Text] [Related]
15. CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses.
Liu B; Dhanda A; Hirani S; Williams EL; Sen HN; Martinez Estrada F; Ling D; Thompson I; Casady M; Li Z; Si H; Tucker W; Wei L; Jawad S; Sura A; Dailey J; Hannes S; Chen P; Chien JL; Gordon S; Lee RW; Nussenblatt RB
J Immunol; 2015 Jun; 194(11):5150-60. PubMed ID: 25911752
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of peripheral blood CD14(bright) CD16+ and CD14(dim) CD16+ monocytes may contribute to the development of retinopathy in patients with juvenile onset type 1 diabetes.
Ryba-Stanisławowska M; Myśliwska J; Juhas U; Myśliwiec M
APMIS; 2015 Sep; 123(9):793-9. PubMed ID: 26200806
[TBL] [Abstract][Full Text] [Related]
17. Activated Platelets Convert CD14
Lee SJ; Yoon BR; Kim HY; Yoo SJ; Kang SW; Lee WW
Front Immunol; 2020; 11():611133. PubMed ID: 33488616
[TBL] [Abstract][Full Text] [Related]
18. A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets.
Ong SM; Teng K; Newell E; Chen H; Chen J; Loy T; Yeo TW; Fink K; Wong SC
Front Immunol; 2019; 10():1761. PubMed ID: 31402918
[TBL] [Abstract][Full Text] [Related]
19. CD14
Tsukamoto M; Seta N; Yoshimoto K; Suzuki K; Yamaoka K; Takeuchi T
Arthritis Res Ther; 2017 Feb; 19(1):28. PubMed ID: 28183329
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
